Send to

Choose Destination
Front Aging Neurosci. 2014 May 14;6:95. doi: 10.3389/fnagi.2014.00095. eCollection 2014.

Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition.

Author information

Molecular Neurology Unit, Center of Excellence on Aging (Ce.S.I.) Chieti, Italy.
CNR-Institute for Biomedical Technologies, Padua "Metalloproteins" Unit, Department of Biology, University of Padua Padua, Italy.


Cognitive impairment is the final outcome of a complex network of molecular mechanisms ultimately leading to dementia. Despite major efforts aimed at unraveling the molecular determinants of dementia of Alzheimer type (DAT), effective disease-modifying approaches are still missing. An interesting and still largely unexplored avenue is offered by nutraceutical intervention. For instance, robust epidemiological data have suggested that moderate intake of red wine may protect against several age-related pathological conditions (i.e., cardiovascular diseases, diabetes, and cancer) as well as DAT-related cognitive decline. Wine is highly enriched in many polyphenols, including resveratrol. Resveratrol is a well recognized antioxidant which may modulate metal ion deregulation outcomes as well as main features of the Alzheimer's disease (AD) brain. The review will discuss the potentiality of resveratrol as a neuroprotectant in dementia in relation to the oxidative stress produced by amyloid and metal dysmetabolism.


Alzheimer’s disease; aging; aluminum; copper; iron; metal ions; resveratrol; zinc

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center